A Google corporate logo hangs above the entrance to their office at St. John’s Terminal on March 11, 2025, in New York City.
Gary Hershorn | Corbis News | Getty Images
Google on Tuesday announced health-care updates to Search, including a way for people with specific health conditions to compare their experiences with others.
The company unveiled a new feature called “What People Suggest,” which uses AI to pull together online commentary from patients with similar diagnoses. A patient with arthritis would be able to look up how other people with the condition approach exercise, for instance. The feature is available on mobile devices in the U.S., Google said.
Google said it has also expanded its knowledge panels, or the information boxes that appear to the right of search results, to cover “thousands” more health topics. The panels are coming to new countries and languages, including Spanish, Japanese and Portuguese, starting on mobile devices.
The tech giant has launched several health-care projects and features over the years, but it has struggled to outline a consistent business strategy within the sector. The company built out a formal Google Health unit starting around 2018, which swelled to more than 500 employees, but it was dissolved in 2021.
Karen DeSalvo, Google’s chief health officer, told CNBC months later that the company was “still all-in on health.”
Google introduced artificial intelligence summaries called AI Overviews last year, and the feature shows a quick summary of answers to search questions at the very top of Search. The rollout was rocky, as users were quick to share examples AI tool giving incorrect and controversial responses, like encouraging users to add glue to pizza.
AI Overviews appear for some health-related queries, like “How do I know if I have the flu?” But some experts have encouraged users to use caution with these answers, according to a December report from The Senior List. Out of more than 200 health searches, a panel of medical experts said 70% Google’s AI Overviews were considered risky.
Google said Tuesday that recent health-focused advancements with its Gemini models have allowed the company to improve AI Overviews for health topics.
In late 2023, Google announced MedLM, a suite of AI models designed specifically for health-care, to help clinicians and researchers carry out complex studies, summarize doctor-patient interactions and complete other tasks.
The company also unveiled Vertex AI Search for Healthcare that year, which is a generative AI tool that clinicians can use to search for information across disparate medical records.
Watch: Google to acquire cloud security startup Wiz for $32 billion.
OpenAI on Tuesday launched a subscription plan in India priced at 399 rupees ($4.57) a month, the ChatGPT maker’s most affordable offering yet, as it looks to grow in its second-largest market by user base.
The new plan, called ChatGPT Go, provides expanded access to the latest model GPT‑5, and other features at a lower cost, the Microsoft-backed firm said in a statement on its website.
Nick Turley, who leads ChatGPT, said in a social media post that the plan provides 10 times more message limits, image generations and file uploads, plus double the memory compared to the free tier.
“Making ChatGPT more affordable has been a key ask from users! We’re rolling out Go in India first and will learn from feedback before expanding to other countries,” Turley added.
OpenAI currently has two other paid plans: ChatGPT Plus, which costs 1,999 rupees a month in India or $20 internationally, and its top-tier ChatGPT Pro, priced at 19,900 rupees a month in India or $200 internationally.
In February, OpenAI CEO Sam Altman met with Indian IT Minister Ashwini Vaishnaw and discussed the country’s plan of creating a low-cost AI ecosystem. Altman lauded India’s rapid AI adoption, calling it an important market for the company.
The company’s latest AI model, GPT-5, was released earlier this month to mixed reviews, with negative feedback resulting in the company eventually restoring access to legacy GPT-4 models for paying customers.
Last month, AI-powered search platform Perplexity partnered with Indian multinational telecommunications company Bharti Airtel to offer all Airtel customers a free 12-month subscription to Perplexity Pro.
That same month, Google announced free one-year subscriptions to its Google AI Pro plan for Indian students aged 18 and over.
Shein is considering moving its headquarters back to China from Singapore in a bid to convince Beijing authorities to approve the online fast-fashion company’s Hong Kong initial public offering, according to a Bloomberg report on Tuesday.
The report said that Shein had gone so far as to consult lawyers about setting up a parent company in mainland China, citing people familiar with the matter. However, it added that there was no guarantee that Shein would act upon the preliminary discussions.
That comes after delays in Shein’s plans for an initial public offering in London that was filed over a year ago, according to Reuters, as the company struggled to secure regulatory approval.
Shein did not respond to a request for comment from CNBC.
A London listing had been seen as a potential boon for the Chinese-founded company, providing it more legitimacy for its international business and access to a deep and mature pool of Western investors.
However, the company has faced headwinds in Western markets this year, with the U.S. President Donald Trump removing a valuable tariff exemption that had helped it maintain low prices on small shipments from China. Lawmakers in some other Western markets are considering similar moves.
Lip-Bu Tan, CEO of Intel, departs the White House in Washington, DC, U.S., on Monday, Aug. 11, 2025.
Alex Wroblewski | Bloomberg | Getty Images
The Trump administration is discussing taking a 10% stake in Intel, according to a Bloomberg report on Tuesday, in a deal that could see the U.S. government become the chipmaker’s largest stakeholder.
As part of a potential deal, the government is also considering converting some or all of Intel’s grants from the 2022 U.S. CHIPS and Science Act into equity in the company, the report said, citing a White House official and other people familiar with the matter.
At the embattled chipmaker’s current market value, a 10% stake would be worth roughly $10.4 billion. Meanwhile, Intel has been awarded about $10.9 billion in Chips Act grants, including $7.9 billion for commercial manufacturing and $3 billion for national security projects.
Stock Chart IconStock chart icon
Intel investors had initially welcomed news of the government investment, which resulted in a share rally of nearly 9% on Aug. 14.
The report noted, however, that it remains unclear if the idea has gained traction broadly within the administration or whether officials have broached the possibility with affected companies.
It added that the exact size of the stake remains in flux, and it remains unclear whether the White House will actually proceed with the plan. Intel and the White House did not immediately respond to CNBC’s queries regarding the report.
Intel, once a dominant force in the U.S. chip industry, has fallen behind global competitors in advanced chip manufacturing. Reviving the former U.S. chip champion has become a national priority in Washington, with reports about a potential government stake in the company first circulating last week.
The company has been the largest recipient of the 2022 Chips Act, passed with bipartisan support under the Biden administration, as part of efforts by Washington to revitalize U.S. leadership in semiconductor manufacturing.
The bill allocated $39 billion in grants for American semiconductor manufacturing projects, with funding committed to many of the world’s chipmakers such as TSMC and Samsung, as well as American chip companies such as Nvidia, Micron and GlobalFoundries.
U.S. President Donald Trump, though supporting the general goals of the Chips Act, has been a vocal critic of the bill and even called for its repeal earlier this year. While republican lawmakers in Washington have been reluctant to act on that call, U.S. Commerce Secretary Howard Lutnick said in June that the administration was renegotiating some of the bill’s grants.
If Intel’s Chip Act funds were to be converted into a potential government stake in the company, it could decrease the total amount of capital infused into the company as part of any deal by Washington.
However, it would serve as the latest example of the Trump administration’s interest in building government-backed national champions in strategic industries.
Intel has struggled to gain an advantage in the artificial intelligence boom and has yet to capture a significant customer for its manufacturing business despite spending heavily on it.
Some analysts have argued that government intervention is essential for the struggling chipmaker and for the sake of U.S. national security. Others contend that Intel’s problems are deeper than funding, and it is not clear how the government can help with that.
Analysts have also noted that Trump may be able to sway companies to buy Intel chips or assist indirectly, through tariffs and regulation.
On Tuesday, it was announced that SoftBank was investing $2 billion in Intel. According to LSEG, the investment is worth about 2% of Intel, making SoftBank the fifth-biggest shareholder.Masayoshi Son, Chairman & CEO of SoftBank Group, said: “This strategic investment reflects our belief that advanced semiconductor manufacturing and supply will further expand in the United States, with Intel playing a critical role.”
Intel investors had initially welcomed news of the government investment, which resulted in a share rally of nearly 9% on Aug. 14. Shares of Intel fell over 3% on Monday on the Bloomberg report, but rebounded by more than 5% in overnight trading on the trading platform Robinhood following news of a Softbank investment.
Intel CEO Lip-Bu Tan, who was appointed in March 2025, met with Trump at the White House last week, after the U.S. president had called for his ousting due to his past ties to China.
After the meeting, Trump had changed his tune on the Intel chief, saying he had “an amazing story.” It’s unclear if a potential government stake in the company had been discussed at the time.